Use of microorganisms for reducing the level of trimethylamine in a human body cavity, in particular for the treatment of trimethylaminuria or of bacterial vaginosis and the prevention of cardiovascular diseases

作者: Corinne Malpuech-Brugere , Jean-François Brugere , Guillaume Borrel , Paul William O'toole , Monique Alric

DOI:

关键词:

摘要: Composition containing a microorganism, preferably an Archaea, expressing TMA methyltransferase and methyl group acceptor corrinoid protein, capable of metabolizing trimethylamine (TMA) in the presence hydrogen human cavity, such as intestine or vagina, for use medicament treating, reducing eliminating at level cavity. In addition, composition protein. These compositions are treating trimethylaminuria, vaginal fluids case bacterial vaginosis odours due to TMA. also plasma TMAO, preventing formation atheroma plaques and/or cardiovascular diseases.

参考文章(25)
Franklin Faping Duan, John C. March, Commensal bacteria as signal mediators within a mammalian host ,(2009)
Bruce L. Levison, Stanley L. Hazen, Zeneng Wang, Trimethylamine-containing compounds for diagnosis and prediction of disease ,(2010)
Joel Hirsch Weiner, Raymond Joseph Turner, Compositions and methods for protein secretion ,(1998)
Diego P. Morgavi, Estelle Rathahao-Paris, Milka Popova, Julien Boccard, Kristian F. Nielsen, Hamid Boudra, Rumen microbial communities influence metabolic phenotypes in lambs Frontiers in Microbiology. ,vol. 6, pp. 1060- 1060 ,(2015) , 10.3389/FMICB.2015.01060
Bédis Dridi, Didier Raoult, Michel Drancourt, Archaea as emerging organisms in complex human microbiomes Anaerobe. ,vol. 17, pp. 56- 63 ,(2011) , 10.1016/J.ANAEROBE.2011.03.001
Kenichi Sakakura, Masataka Nakano, Fumiyuki Otsuka, Elena Ladich, Frank D. Kolodgie, Renu Virmani, Pathophysiology of atherosclerosis plaque progression. Heart Lung and Circulation. ,vol. 22, pp. 399- 411 ,(2013) , 10.1016/J.HLC.2013.03.001
Jungwook Chin, K.A. Foyez Mahmud, Sung Eun Kim, Kyeongsoon Park, Youngro Byun, Insight of current technologies for oral delivery of proteins and peptides Drug Discovery Today: Technologies. ,vol. 9, pp. e105- e112 ,(2012) , 10.1016/J.DDTEC.2012.04.005